Meg Hooton

R&D

Meg Hooton, President of IQVIA Biotech, leads the organisation, providing clinical development solutions for biotech and emerging biopharma clients.

News

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.